{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:42:45Z","timestamp":1793148165271,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijcha.2023.101189","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T22:49:39Z","timestamp":1679957379000},"page":"101189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety"],"prefix":"10.1016","volume":"45","author":[{"given":"Gregor","family":"Goetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcha.2023.101189_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccl.2013.11.002","article-title":"The role of the wearable cardioverter defibrillator in clinical practice","volume":"32","author":"Chung","year":"2014","journal-title":"Cardiol. Clin."},{"issue":"41","key":"10.1016\/j.ijcha.2023.101189_bb0010","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2023.101189_bb0015","author":"ZOLL Medical Corporation"},{"key":"10.1016\/j.ijcha.2023.101189_bb0020","series-title":"Decision Support Document 103\/ Update 2018","article-title":"Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018","author":"Chiarolla","year":"2019"},{"key":"10.1016\/j.ijcha.2023.101189_bb0025","author":"Food and Drug Administration (FDA)"},{"issue":"7","key":"10.1016\/j.ijcha.2023.101189_bb0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2015.03.061","article-title":"Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: a cost-effectiveness evaluation","volume":"12","author":"Healy","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcha.2023.101189_bb0035","first-page":"257","article-title":"Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study","volume":"10","author":"Ettinger","year":"2017","journal-title":"Med. Devices (Auckl)"},{"key":"10.1016\/j.ijcha.2023.101189_bb0040","author":"Maceira Rozas"},{"issue":"2","key":"10.1016\/j.ijcha.2023.101189_bb0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacep.2018.11.011","article-title":"Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a systematic review and Meta-analysis","volume":"5","author":"Masri","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"issue":"13","key":"10.1016\/j.ijcha.2023.101189_bb0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable cardioverter-defibrillator after myocardial infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2023.101189_bb0055","author":"Mandrola"},{"issue":"6","key":"10.1016\/j.ijcha.2023.101189_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc1816889","article-title":"Wearable cardioverter\u2013defibrillator after myocardial infarction","volume":"380","author":"Stecker","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2023.101189_bb0065","unstructured":"G. Goetz, B. Wernly, Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022. Decision Support Document 103\/ 2. Update 2022.: 2022 [cited 24.10.2022]. Available from: https:\/\/eprints.aihta.at\/1407\/."},{"issue":"5","key":"10.1016\/j.ijcha.2023.101189_bb0070","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"issue":"7","key":"10.1016\/j.ijcha.2023.101189_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijcha.2023.101189_bb0080","author":"European Network for Health Technology Assessment (EUnetHTA)"},{"issue":"4","key":"10.1016\/j.ijcha.2023.101189_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0266462320000379","article-title":"Effectiveness, efficacy, and safety of wearable cardioverter-defibrillators in the treatment of sudden cardiac arrest \u2013 results from a health technology assessment","volume":"36","author":"Aidelsburger","year":"2020","journal-title":"Int. J. Technol. Assess. Health Care"},{"issue":"4","key":"10.1016\/j.ijcha.2023.101189_bb0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ijcha.2023.101189_bb0095","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj."},{"key":"10.1016\/j.ijcha.2023.101189_bb0100","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj."},{"key":"10.1016\/j.ijcha.2023.101189_bb0105","author":"Institute of Health Economics (IHE)"},{"issue":"5","key":"10.1016\/j.ijcha.2023.101189_bb0110","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jce.14404","article-title":"Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: as-treated and per-protocol analyses","volume":"31","author":"Olgin","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"6","key":"10.1016\/j.ijcha.2023.101189_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/JCN.0000000000000864","article-title":"Increased quality of life among newly diagnosed patients with heart failure with reduced ejection fraction in the months after initiation of guideline-directed medical therapy and wearable cardioverter defibrillator prescription","volume":"36","author":"Burch","year":"2021","journal-title":"J. Cardiovasc. Nurs."},{"issue":"9","key":"10.1016\/j.ijcha.2023.101189_bb0120","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.hrthm.2018.04.014","article-title":"Experience with the wearable cardioverter-defibrillator in older patients: results from the prospective registry of patients using the wearable cardioverter-defibrillator","volume":"15","author":"Daimee","year":"2018","journal-title":"Heart Rhythm."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00392-017-1159-1","article-title":"Usefulness of the WCD in patients with suspected tachymyopathy","volume":"107","author":"Erath","year":"2018","journal-title":"Clin. Res. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2023.101189_bb0130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00392-016-1054-1","article-title":"The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients","volume":"106","author":"Erath","year":"2017","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/europace\/euaa268","article-title":"Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study","volume":"23","author":"Garcia","year":"2021","journal-title":"Europace."},{"issue":"3","key":"10.1016\/j.ijcha.2023.101189_bb0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.hrthm.2020.11.025","article-title":"Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator","volume":"18","author":"Goldenberg","year":"2021","journal-title":"Heart Rhythm."},{"issue":"17","key":"10.1016\/j.ijcha.2023.101189_bb0145","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","article-title":"Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry)","volume":"132","author":"Kutyifa","year":"2015","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.ijcha.2023.101189_bb0150","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/pace.13448","article-title":"One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II registry)","volume":"41","author":"Kutyifa","year":"2018","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"Fi2","key":"10.1016\/j.ijcha.2023.101189_bb0155","first-page":"f225","article-title":"Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death. Europace","volume":"20","author":"Kutyifa","year":"2018"},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1474515118790365","article-title":"Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD registry","volume":"18","author":"Odeneg","year":"2019","journal-title":"Eur. J. Cardiovasc. Nurs."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12872-018-0790-8","article-title":"Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting","volume":"18","author":"R\u00f6ger","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"10.1016\/j.ijcha.2023.101189_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030893","article-title":"The wearable cardioverter-defibrillator: experience in 153 patients and a long-term follow-up","volume":"9","author":"Rosenkaimer","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2023.101189_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10840-020-00898-5","article-title":"The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital","volume":"62","author":"Sinha","year":"2021","journal-title":"J. Interv. Card. Electrophysiol."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00392-020-01657-2","article-title":"Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry","volume":"110","author":"Veltmann","year":"2021","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2023.101189_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213261","article-title":"Anxiety, depression and quality of life in acute high risk cardiac disease patients eligible for wearable cardioverter defibrillator: results from the prospective multicenter CRED-registry","volume":"14","author":"Weiss","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2023.101189_bb0190","author":"Zoll Medical Corporation"},{"issue":"27","key":"10.1016\/j.ijcha.2023.101189_bb0195","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/eurheartj\/ehaa382","article-title":"Implementing the new European regulations on medical devices\u2014clinical responsibilities for evidence-based practice: a report from the regulatory Affairs Committee of the European Society of cardiology","volume":"41","author":"Fraser","year":"2020","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcha.2023.101189_bb0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s43441-019-00094-2","article-title":"The medical device regulation of the European Union intensifies focus on clinical benefits of devices","volume":"54","author":"Wilkinson","year":"2020","journal-title":"Ther. Innov. Regul. Sci."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1744133120000158","article-title":"Neither protective nor harmonized: the crossborder regulation of medical devices in the EU","volume":"16","author":"Jarman","year":"2021","journal-title":"Health Econ. Policy Law."},{"key":"10.1016\/j.ijcha.2023.101189_bb0210","author":"Centre of Evidence Based Medicine"},{"key":"10.1016\/j.ijcha.2023.101189_bb0215","author":"Victoria"},{"issue":"11","key":"10.1016\/j.ijcha.2023.101189_bb0220","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00392-022-02003-4","article-title":"Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?","volume":"111","author":"Israel","year":"2022","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCHEARTFAILURE.111.964569","article-title":"Interventions to enhance adherence to medications in patients with heart failure: a systematic review","volume":"5","author":"Molloy","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"7003","key":"10.1016\/j.ijcha.2023.101189_bb0230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"Bmj."},{"issue":"36","key":"10.1016\/j.ijcha.2023.101189_bb0235","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2023.101189_bb0240","author":"Blue Cross Blue Shield Association"},{"key":"10.1016\/j.ijcha.2023.101189_bb0245","first-page":"10","article-title":"Wearable cardioverter-defibrillator used as a Telemonitoring system in a real-life heart failure unit setting","author":"Blockhaus","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/s22010022","article-title":"Multiparameter monitoring with a wearable cardioverter defibrillator","volume":"22","author":"Rohrer","year":"2021","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.ijcha.2023.101189_bb0255","first-page":"93","article-title":"Telemedical concepts for heart failure patients treated with a wearable cardioverter defibrillator","volume":"271","author":"Reiss","year":"2020","journal-title":"Stud. Health Technol. Inform."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12874-019-0699-7","article-title":"Bayes factors for superiority, non-inferiority, and equivalence designs","volume":"19","author":"van Ravenzwaaij","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.ijcha.2023.101189_bb0265","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacep.2017.10.011","article-title":"The wearable cardioverter-defibrillation: an investment worth making or needing further investigation?","volume":"4","author":"Adelstein","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ijcha.2023.101189_bb0270","first-page":"1","article-title":"The need for increased pragmatism in cardiovascular clinical trials","author":"Usman","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcha.2023.101189_bb0275","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/jce.14708","article-title":"Collaborative care for the wearable cardioverter defibrillator patient: getting the patient and medical team \"vested and active\"","volume":"31","author":"Sears","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"5","key":"10.1016\/j.ijcha.2023.101189_bb0280","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jce.14403","article-title":"Patient selection for wearable cardioverter defibrillator therapy after myocardial infarction: how can we incorporate compliance into decision-making?","volume":"31","author":"Younis","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcha.2023.101189_bb0285","author":"Deneke","year":"2023"},{"issue":"11","key":"10.1016\/j.ijcha.2023.101189_bb0290","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/clc.23709","article-title":"Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: clinical and economic implications","volume":"44","author":"Boriani","year":"2021","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcha.2023.101189_bb0295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2022.04.003","article-title":"The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: economic and clinical implications from a health technology assessment perspective","volume":"356","author":"Botto","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029596","article-title":"'Not clinically effective but cost-effective' - paradoxical conclusions in randomised controlled trials with 'doubly null' results: a cross-sectional study","volume":"10","author":"Raftery","year":"2020","journal-title":"BMJ Open"},{"issue":"9912","key":"10.1016\/j.ijcha.2023.101189_bb0305","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(13)62329-6","article-title":"Biomedical research: increasing value, reducing waste","volume":"383","author":"Macleod","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.ijcha.2023.101189_bb0310","series-title":"Cochrane Handbook for Systematic Re-views of Interventions, Second Edition","article-title":"Chapter 24: Includ-ing non-randomized studies on intervention effects","author":"Reeves BC","year":"2023"},{"issue":"1","key":"10.1016\/j.ijcha.2023.101189_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardfail.2011.09.004","article-title":"Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator","volume":"18","author":"Saltzberg","year":"2012","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.ijcha.2023.101189_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194496","article-title":"Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator","volume":"13","author":"Skowasch","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijcha.2023.101189_bb0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacep.2016.09.002","article-title":"Benefit of the wearable cardioverter-defibrillator in protecting patients after implantable-cardioverter defibrillator explant: results from the National Registry","volume":"3","author":"Ellenbogen","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ijcha.2023.101189_bb0330","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2018.08.017","article-title":"Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD","volume":"272","author":"Kaspar","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2023.101189_bb0335","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ehf2.13353","article-title":"Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis","volume":"8","author":"Tscholl","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcha.2023.101189_bb0340","author":"Food and Drug Administration (FDA)"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906723000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906723000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:12:28Z","timestamp":1762492348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906723000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":68,"alternative-id":["S2352906723000209"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2023.101189","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2023.101189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101189"}}